FDA — authorised 30 May 1973
- Application: ANDA083003
- Marketing authorisation holder: TABLICAPS
- Local brand name: STILBESTROL
- Indication: TABLET, DELAYED RELEASE — ORAL
- Status: approved
🇺🇸 Estrobene in United States
FDA authorised Estrobene on 30 May 1973
Marketing authorisations
FDA
- Application: NDA004040
- Marketing authorisation holder: LILLY
- Local brand name: DIETHYLSTILBESTROL
- Indication: SUPPOSITORY — VAGINAL
- Status: approved
FDA
- Application: NDA004056
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Local brand name: STILBESTROL
- Indication: SUPPOSITORY — VAGINAL
- Status: approved
FDA
- Application: NDA004041
- Marketing authorisation holder: LILLY
- Local brand name: DIETHYLSTILBESTROL
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA083002
- Marketing authorisation holder: TABLICAPS
- Local brand name: STILBESTROL
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA083004
- Marketing authorisation holder: TABLICAPS
- Local brand name: STILBESTROL
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA083005
- Marketing authorisation holder: TABLICAPS
- Local brand name: STILBESTROL
- Indication: TABLET, DELAYED RELEASE — ORAL
- Status: approved
FDA
- Application: ANDA083006
- Marketing authorisation holder: TABLICAPS
- Local brand name: STILBESTROL
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA083007
- Marketing authorisation holder: TABLICAPS
- Local brand name: STILBESTROL
- Indication: TABLET, DELAYED RELEASE — ORAL
- Status: approved
FDA
- Status: approved
FDA
- Application: NDA004039
- Marketing authorisation holder: LILLY
- Local brand name: DIETHYLSTILBESTROL
- Indication: TABLET, DELAYED RELEASE — ORAL
- Status: approved
Estrobene in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in United States
Frequently asked questions
Is Estrobene approved in United States?
Yes. FDA authorised it on 30 May 1973; FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Estrobene in United States?
TABLICAPS holds the US marketing authorisation.